The Vanguard Group 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-12 3:58 pm Unchanged | 2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | The Vanguard Group | 2,605,753 6.040% | 0 (Unchanged) | Filing |
2024-11-04 11:56 am Purchase | 2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | The Vanguard Group | 2,605,753 6.040% | 2,605,753 (New Position) | Filing |